Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients

Keyphrases

• Antimicrobial Resistance 100%
• Biofilm 100%
• Lung Infection 100%
• Cystic Fibrosis 100%
• Respiratory Infection 100%
• Antibiotics 66%
• Pharmacokinetics 33%
• Therapeutic Target 33%
• Airway 33%
• Therapeutic Challenges 33%
• Pseudomonas Aeruginosa (P. aeruginosa) 33%
• Lung 33%
• Pharmacodynamics 33%
• Biofilm Formation 33%
• Quorum Sensing Inhibitors 33%
• Chronic Inflammation 33%
• Vicious Circle 33%
• Adaptive Evolution 33%
• Antimicrobial Susceptibility 33%
• General Mechanism 33%
• Antibiofilm Compounds 33%
• New Drug Delivery Systems 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antimicrobial Resistance 100%
• Cystic Fibrosis 100%
• Lung Infection 100%
• Respiratory Tract Infection 100%
• Pharmacokinetics 33%
• Chronic Inflammation 33%
• Antiinfective Agent 33%
• Infection 33%
• Antibiotics 33%
• Pharmacodynamics 33%
• Pseudomonas aeruginosa 33%
• Antibiotic Agent 33%
• Drug Delivery System 33%

Immunology and Microbiology

• Antimicrobial Resistance 100%
• Biofilm 100%
• Pharmacokinetics 20%
• Pseudomonas aeruginosa 20%
• Quorum Sensing 20%
• Evolutionary Adaptation 20%
• Pharmacodynamics 20%